The effect of IL-22 on tumor growth was investigated by using an in vivo model of HCC: a significant increase in tumor volume was associated with enhanced phosphorylation of STAT3 as well as upregulation of cyclin D1 [85]. The gene discussed is STAT3; the disease is hepatocellular carcinoma.